Jajodia, AnkushAnkushJajodiaEbner, LukasLukasEbnerHeidinger, BenediktBenediktHeidingerChaturvedi, ArvindArvindChaturvediProsch, HelmutHelmutProsch2024-09-022024-09-022020-05-11https://boris-portal.unibe.ch/handle/20.500.12422/35926Coronavirus Disease-2019 (COVID-19) originated in the Wuhan, Hubei Province, China in November 2019 and has since been declared a pandemic by the WHO. COVID-19 is an acute infectious disease, primarily affecting the respiratory system. Currently, real-time reverse transcription polymerase chain reaction (RT-PCR) performed on respiratory specimens is considered the reference by which to diagnose COVID-19. However, the limitations of RT-PCR, specifically, the fact that it is time-consuming and inadequate for the assessment of disease severity, have affected the process of epidemiological disease containment and has taken a toll on the healthcare management chain. As the risk of infection for other patients and personnel must be kept to a minimum, the indications for imaging have to be carefully considered. Imaging is primarily performed in patients with a negative RT-PCR, but a high clinical suspicion of COVID-19, or, in patients with diagnosed COVID-19 who are suffering from moderate to severe symptoms. In this article, we review the typical imaging findings in COVID-19, the differential diagnoses, and common complications.enCOVID-19 ground-glass infection pneumonia600 - Technology::610 - Medicine & healthImaging in corona virus disease 2019 (COVID-19)-A scoping review.article10.7892/boris.1440663239556710.1016/j.ejro.2020.100237